{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:40:21Z","timestamp":1793313621261,"version":"4.5.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":721,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AstraZeneca"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Bronchiectasis is a chronic, progressive disease of bronchial dilation, inflammation, and scarring leading to impaired mucociliary clearance and increased susceptibility to infection. Identified causes include previous severe respiratory infections. A small, single-center UK study demonstrated a reduction in bronchiectasis exacerbations during the first year of the coronavirus disease (COVID-19) pandemic. No studies have been conducted in a U.S. (commercially insured) cohort to date.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To explore the impact of the COVID-19 pandemic on the frequency of exacerbations in a large cohort of commercially insured U.S. patients with bronchiectasis by testing the hypothesis that U.S. patients with bronchiectasis had fewer exacerbations during the pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective observational cohort study used health insurance claims data from Optum\u2019s deidentified Clinformatics Data Mart database, which included U.S. patients and their covered dependents. Eligible patients were \u2a7e18\u2009years of age with bronchiectasis; patients with other respiratory conditions were excluded. The main study cohort excluded patients with frequent asthma and\/or chronic obstructive pulmonary disease diagnoses. The primary objective was to compare the bronchiectasis exacerbation rates before and during the COVID-19 pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median number of exacerbations per patient per year decreased significantly from the year before the COVID-19 pandemic to the first year of the pandemic (1 vs. 0; P\u2009&amp;lt;\u20090.01). More patients had zero exacerbations during the first year of the pandemic than the year prior (57% vs. 24%; McNemar\u2019s chi-square\u2009=\u2009122.56; P\u2009&amp;lt;\u20090.01).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In a U.S. population-based study of patients with International Classification of Diseases codes for bronchiectasis, the rate of exacerbations during Year 1 of the COVID-19 pandemic was reduced compared with the 2-year time period preceding the pandemic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202211-944oc","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T11:40:03Z","timestamp":1699962003000},"page":"261-270","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":17,"title":["Effect of COVID-19 on Bronchiectasis Exacerbation Rates: A Retrospective U.S. Insurance Claims Study"],"prefix":"10.1093","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4231-6682","authenticated-orcid":false,"given":"Annika","family":"\u00c5strand","sequence":"first","affiliation":[{"name":"Late-Stage Development, Respiratory & Immunology, AstraZeneca, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Kiddle","sequence":"additional","affiliation":[{"name":"Data Science & Advanced Analytics, Data Science & Artificial Intelligence, Research & Development, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohith","family":"Siva Ganesh Mudedla","sequence":"additional","affiliation":[{"name":"ZS Associates India Pvt. Ltd., Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchita","family":"Porwal","sequence":"additional","affiliation":[{"name":"ZS Associates India Pvt. Ltd., Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Chafekar","sequence":"additional","affiliation":[{"name":"ZS Associates India Pvt. Ltd., Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubh","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Integrated Evidence, ZS Associates, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Seminario","sequence":"additional","affiliation":[{"name":"Late-Stage Development, Respiratory & Immunology, AstraZeneca, Gaithersburg, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[{"name":"Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Psallidas","sequence":"additional","affiliation":[{"name":"Late-Stage Development, Respiratory & Immunology, AstraZeneca, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"2026012203135747200_bib1","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1513\/AnnalsATS.201507-472OC","article-title":"Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity","volume":"12","author":"Lonni","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203135747200_bib2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1378\/chest.08-0776","article-title":"Bronchiectasis","volume":"134","author":"O\u2019Donnell","year":"2008","journal-title":"Chest"},{"key":"2026012203135747200_bib3","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the US Bronchiectasis Research Registry","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest"},{"key":"2026012203135747200_bib4","doi-asserted-by":"crossref","first-page":"1700051","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"Hill","year":"2017","journal-title":"Eur Respir J"},{"key":"2026012203135747200_bib5","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1378\/chest.14-1961","article-title":"The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: a prospective study","volume":"147","author":"Gao","year":"2015","journal-title":"Chest"},{"key":"2026012203135747200_bib6","doi-asserted-by":"crossref","first-page":"1800328","DOI":"10.1183\/13993003.00328-2018","article-title":"The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions","volume":"52","author":"Polverino","year":"2018","journal-title":"Eur Respir J"},{"key":"2026012203135747200_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cyto.2017.08.005","article-title":"The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis","volume":"99","author":"Tsikrika","year":"2017","journal-title":"Cytokine"},{"key":"2026012203135747200_bib8","doi-asserted-by":"crossref","first-page":"642503","DOI":"10.1155\/2015\/642503","article-title":"Neutrophilic bronchial inflammation correlates with clinical and functional findings in patients with noncystic fibrosis bronchiectasis","volume":"2015","author":"Dente","year":"2015","journal-title":"Mediators Inflamm"},{"key":"2026012203135747200_bib9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.15585\/mmwr.mm7029a1","article-title":"Changes in influenza and other respiratory virus activity during the COVID-19 pandemic\u2014United States, 2020\u20132021","volume":"70","author":"Olsen","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026012203135747200_bib10","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1038\/s41467-021-23440-1","article-title":"Impact of COVID-19 outbreaks and interventions on influenza in China and the United States","volume":"12","author":"Feng","year":"2021","journal-title":"Nat Commun"},{"key":"2026012203135747200_bib11","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ajic.2021.06.002","article-title":"Distribution of spreading viruses during COVID-19 pandemic: effect of mitigation strategies","volume":"49","author":"K\u0131ymet","year":"2021","journal-title":"Am J Infect Control"},{"key":"2026012203135747200_bib12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1164\/rccm.202105-1137LE","article-title":"The impact of the COVID-19 pandemic on exacerbations and symptoms in bronchiectasis: a prospective study","volume":"204","author":"Crichton","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203135747200_bib13","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3390\/antibiotics11081096","article-title":"Impact of the SARS-CoV-2 virus pandemic on patients with bronchiectasis: a multicenter study","volume":"11","author":"Mart\u00ednez-Vergara","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"2026012203135747200_bib14","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","article-title":"Characterization of the \u201cfrequent exacerbator phenotype\u201d in bronchiectasis","volume":"197","author":"Chalmers","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203135747200_bib15","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.2147\/COPD.S322036","article-title":"COPD exacerbation history and impact on future exacerbations\u20148-year retrospective observational database cohort study from Germany","volume":"16","author":"Vogelmeier","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012203135747200_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1164\/rccm.201811-2122ED","article-title":"Can we predict exacerbations of asthma?","volume":"199","author":"Sears","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203135747200_bib17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/thoraxjnl-2020-216512","article-title":"Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data","volume":"76","author":"Shah","year":"2021","journal-title":"Thorax"},{"key":"2026012203135747200_bib18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12916-021-02000-w","article-title":"Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales","volume":"19","author":"Alsallakh","year":"2021","journal-title":"BMC Med"},{"key":"2026012203135747200_bib19","doi-asserted-by":"crossref","first-page":"142374","DOI":"10.1016\/j.scitotenv.2020.142374","article-title":"Early observations on the impact of the COVID-19 lockdown on air quality trends across the UK","volume":"754","author":"Ropkins","year":"2021","journal-title":"Sci Total Environ"},{"key":"2026012203135747200_bib20","doi-asserted-by":"crossref","first-page":"140496","DOI":"10.1016\/j.scitotenv.2020.140496","article-title":"Air quality changes in New York City during the COVID-19 pandemic","volume":"742","author":"Zangari","year":"2020","journal-title":"Sci Total Environ"},{"key":"2026012203135747200_bib21","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/eurpub\/ckab047","article-title":"Assessing the indirect effects of COVID-19 on healthcare delivery, utilization and health outcomes: a scoping review","volume":"31","author":"Roy","year":"2021","journal-title":"Eur J Public Health"},{"key":"2026012203135747200_bib22","doi-asserted-by":"crossref","first-page":"e045343","DOI":"10.1136\/bmjopen-2020-045343","article-title":"Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review","volume":"11","author":"Moynihan","year":"2021","journal-title":"BMJ Open"},{"key":"2026012203135747200_bib23","doi-asserted-by":"crossref","first-page":"e2024984","DOI":"10.1001\/jamanetworkopen.2020.24984","article-title":"Changes in health services use among commercially insured US populations during the COVID-19 pandemic","volume":"3","author":"Whaley","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026012203135747200_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ccm.2022.11.018","article-title":"The impact of coronavirus disease 2019 on viral, bacterial, and fungal respiratory infections","volume":"44","author":"Losier","year":"2023","journal-title":"Clin Chest Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/2\/261\/66018117\/annalsats_21_2_261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/2\/261\/66018117\/annalsats_21_2_261.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:14:53Z","timestamp":1769069693000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/21\/2\/261\/8382056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,1]]},"published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202211-944oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2024,2,1]]},"assertion":[{"value":"2022-11-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}